by Richard Daverman, PhD
April 14, 2014 -- Chindex, the US-based operator of China hospitals and clinics, received a new takeover offer of $23 per share from an undisclosed entity. The offer is an 18% improvement on the $19.50 bid, made in February, from a group comprised of Fosun Pharma, TPG (a US private equity group) and Roberta Lipson, CEO of Chindex. A definitive agreement has been negotiated with the entity behind the latest offer, which is all-cash and not subject to any financing contingencies. More details....
Stock Symbols: (NSDQ: CHDX) (SHA: 600196; HK: 2196)
Help employers find you! Check out all the jobs and post your resume.
